Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)
Fluticasone Propionate Aerosol, Metered
Product Images NDC 50090-6055
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-6055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)
Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)
This appears to be a table of data related to the change in FEV (Forced Expiratory Volume) from a baseline, comparing the impact of various medications at different doses. The medications listed are Placebo and Fluticasone Propionate HFA (at doses of 83, 220, and 440 meg twice daily). The table includes 12 weeks of data, with the endpoint being the evaluation after that timeframe. This data can be used to analyze and compare the effectiveness of different doses of Fluticasone Propionate HFA as a treatment for respiratory conditions.*
Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)
The text provided appears to be a table showing the percentage of subjects with an increase in dose and reduction in dose for Fluticasone Propionate HFA at 440 and 880 meg twice daily. There is also a column for the placebo. However, there is not enough information provided to understand the full context of the table or its purpose.*
Figure A (Fluticasonepropionatehfa Spl Graphic 05)
The product appears to be a metal canister with a dark orange plastic actuator and a mouthpiece. It also comes with a peach cap. More information is not available for the given text.*
Figure B (Fluticasonepropionatehfa Spl Graphic 06)
Figure C (Fluticasonepropionatehfa Spl Graphic 07)
Figure D (Fluticasonepropionatehfa Spl Graphic 08)
Figure E (Fluticasonepropionatehfa Spl Graphic 09)
The text appears to describe different attributes of a mouthpiece, such as its position and color, but it is not clear what object the mouthpiece belongs to or what context it is being used in. Therefore, the description is not specific or useful enough and it is not possible to provide a meaningful interpretation.*
Figure F (Fluticasonepropionatehfa Spl Graphic 10)
This text is a simple direction to exhale or breathe out as much air as possible.*
Figure G (Fluticasonepropionatehfa Spl Graphic 11)
Figure H (Fluticasonepropionatehfa Spl Graphic 12)
Figure I (Fluticasonepropionatehfa Spl Graphic 13)
Figure J (Fluticasonepropionatehfa Spl Graphic 14)
Label Image (Lbl500906055)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
